Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanez

Showing results (851-860 of 916) with videos related to

Pageof 92
Sort By:
Blood Advances|August 25, 2021
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cellsMartina Pennisi, Miriam Sanchez-Escamilla, Jessica R Flynn, et al.
Lancet (London, England)|June 8, 2021
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trialYelena Y Janjigian, Kohei Shitara, Markus Moehler, et al.
Science Translational Medicine|September 29, 2021
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injuryNeil S N Graham, Karl A Zimmerman, Federico Moro, et al.
BMJ Open|June 9, 2022
Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)Benjamin M Davies, Alvaro Yanez Touzet, Oliver D Mowforth, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or BioisostereGwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
JAMA Network Open|January 13, 2023
Emergency Department Pediatric Readiness and Short-term and Long-term Mortality Among Children Receiving Emergency CareCraig D Newgard, Amber Lin, Susan Malveau, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 24, 2024
European clinical practice guideline: managing and treating laryngopharyngeal reflux diseaseJerome R Lechien, Carlos-Miguel Chiesa-Estomba, Stéphane Hans, et al.
Neuro-Oncology|May 13, 2022
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registryAllison L Bartlett, Adam Lane, Brooklyn Chaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 TrialEmmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
Pageof 92

Showing results (851-860 of 916) with videos related to

Sort By:
Pageof 92
Blood Advances|August 25, 2021
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cellsMartina Pennisi, Miriam Sanchez-Escamilla, Jessica R Flynn, et al.
Lancet (London, England)|June 8, 2021
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trialYelena Y Janjigian, Kohei Shitara, Markus Moehler, et al.
Science Translational Medicine|September 29, 2021
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injuryNeil S N Graham, Karl A Zimmerman, Federico Moro, et al.
BMJ Open|June 9, 2022
Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS)Benjamin M Davies, Alvaro Yanez Touzet, Oliver D Mowforth, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Journal of Medicinal Chemistry|November 19, 2019
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or BioisostereGwenaella Rescourio, Ana Z Gonzalez, Salman Jabri, et al.
JAMA Network Open|January 13, 2023
Emergency Department Pediatric Readiness and Short-term and Long-term Mortality Among Children Receiving Emergency CareCraig D Newgard, Amber Lin, Susan Malveau, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 24, 2024
European clinical practice guideline: managing and treating laryngopharyngeal reflux diseaseJerome R Lechien, Carlos-Miguel Chiesa-Estomba, Stéphane Hans, et al.
Neuro-Oncology|May 13, 2022
Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registryAllison L Bartlett, Adam Lane, Brooklyn Chaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 TrialEmmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
Pageof 92